Ardent Health, Inc. ARDT

Healthcare SIC 8062 - Services-General Medical & Surgical Hospitals, NEC NAICS Health Care and Social Assistance › Hospitals › General Medical and Surgical Hospitals derived NYSE

Ardent Health, Inc. was initially formed in Delaware in 2015 as Ardent Health Partners, LLC. On July 17, 2024, Ardent Health Partners, LLC converted from a Delaware limited liability company into a Delaware corporation in connection with its initial public offering and changed its name to Ardent Health Partners, Inc. On June 3, 2025, Ardent Health Partners, Inc. changed its name to Ardent Health, Inc. Ardent Health, Inc. is a holding company that has affiliates that operate acute care hospitals and other healthcare facilities and employ physicians. The terms "Ardent," the "Company," "we," "our" and "us," as used in this Annual Report on Form 10-K ("Annual Report"), refer to Ardent Health, Inc. and its affiliates and, on or prior to July 16, 2024, Ardent Health Partners, LLC and its affiliates, unless stated otherwise or indicated by context. The term "affiliates" includes direct and indirect subsidiaries of Ardent and partnerships and joint ventures in which such subsidiaries are equity owners.

Last close 12.27 2026-10-23
Market cap $1.73B 2026-06-30 share count
52-week range 7.71 - 15.48

Valuation FY2025 figures against the last close

P/S0.3x
P/E12.8x
P/FCF3.7x
EV/EBITDA—
Dividend yield—
Diluted EPS0.96

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021
Revenue $6.32B$5.97B$5.41B$5.13B—
SG&A $140.8M$132.4M$114.6M$75.3M—
Total operating expenses $6.04B$5.60B$5.26B$4.82B—
Pre-tax income $286.4M$363.1M$151.6M$311.5M—
Income tax $56.2M$63.4M$22.6M$46.1M—
Net income $230$300$53.9M$188.9M—
EPS, basic 0.961.590.431.50—
EPS, diluted 0.961.580.431.50—
Shares, diluted (wtd. avg.) 141.5M132.7M126.1M126.1M—

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021
Cash and equivalents $709.6M$556.8M$437.6M$456.1M$718.2M
Receivables $686.1M$743.0M$775.5M——
Inventory $118.6M$115.1M$105.5M——
Total current assets $2.06B$1.83B$1.62B——
Property, plant and equipment —$861.9M$811.1M——
Goodwill $879.5M$852.1M$844.7M$844.7M—
Other intangibles $12.4M————
Total assets $5.29B$4.96B$4.73B——
Accounts payable $457.9M$401.2M$474.5M——
Short-term debt $23.4M$9.2M$18.6M——
Total current liabilities $1.05B$945.4M$994.1M——
Long-term debt $1.08B$1.09B$1.17B——
Total liabilities $3.61B$3.43B$3.65B——
Retained earnings $501.6M$365.8M$155.5M——
Total equity $1.29B$1.13B$1.08B$1.04B$978.3M

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021
Operating cash flow $470.5M$315.0M$221.7M-$38.4M—
Depreciation and amortisation $155.7M$146.3M$140.8M$138.2M—
Investing cash flow -$214.2M-$220.5M-$138.0M$46.6M—
Financing cash flow -$103.5M$24.6M-$102.3M-$270.3M—
Dividends paid —$0$0$174.8M—

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001628280-26-024244.

Plot the figures US dollars

Income statement Revenue Cost of revenue Gross profit R&D SG&A Total operating expenses Operating income Interest expense Pre-tax income Income tax Net income EPS, basic EPS, diluted Shares, diluted (wtd. avg.)
Balance sheet Cash and equivalents Short-term investments Receivables Inventory Total current assets Property, plant and equipment Goodwill Other intangibles Total assets Accounts payable Short-term debt Total current liabilities Long-term debt Total liabilities Retained earnings Total equity
Cash flow Operating cash flow Depreciation and amortisation Stock-based compensation Capital expenditure Investing cash flow Financing cash flow Dividends paid Buybacks
  • Revenue
  • Gross profit
  • Net income
Revenue, Gross profit, Net income by fiscal year, in US dollars The same figures are in the table below this chart. 0 2B 4B 6B 8B Revenue, FY2022: 5.1B Net income, FY2022: 188.9M Revenue, FY2023: 5.4B Net income, FY2023: 53.9M Revenue, FY2024: 6B Net income, FY2024: 300 Revenue, FY2025: 6.3B Net income, FY2025: 230 FY2021 FY2022 FY2023 FY2024 FY2025
Fiscal year FY2021FY2022FY2023FY2024FY2025
Revenue — $5.13B $5.41B $5.97B $6.32B
Gross profit — — — — —
Net income — $188.9M $53.9M $300 $230

Recent filings and events

  • Other event The catch-all. The company chose to disclose something that fits no other item, so the content is whatever it says it is. Item 8.01
  • Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
  • Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
  • Officer or director change Item 5.02
  • Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
  • Shareholder vote The results of the annual meeting or a special vote. Item 5.07
  • Results announced Item 2.02
  • Officer or director change Item 5.02
  • Annual report filed A new 10-K. The figures and the business description on this site come from it. Form 10-K
  • Results announced Item 2.02
  • Regulation FD disclosure Item 7.01
  • Other event Item 8.01

Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.

Others in SIC 8062

TickerCompanyMarket capP/ERevenue growth
HCA HCA Healthcare, Inc. $104.05B 16.6x 7.1%
THC TENET HEALTHCARE CORP $21.62B 17.3x 3.1%
UHS UNIVERSAL HEALTH SERVICES INC $11.15B 8.1x 9.7%
SGRY Surgery Partners, Inc. $2.06B — 6.2%
CYH COMMUNITY HEALTH SYSTEMS INC $411.7M 0.8x -1.2%